As pharmaceutical and biotech companies continue to build advantageous, innovative relationships with advocacy organizations, ensuring compliant interaction during collaboration is a continued challenge, given the evolving regulatory and compliance frameworks. Advocacy executives are faced with multiple compliance concerns from off-label use of therapies and the promotion of products to navigating interest areas and defining the scope of patient groups. Ensuring advocacy professionals have a thorough understanding of compliant boundaries starts with proper education and relationships that are clearly defined.
- Working with legal/compliance teams to ensure compliance procedures
- Training to have compliant conversations when working with PAGs
- Defining compliant relationships and conversations
- Best practices in defining compliant patient group collaboration
Vice President, Business Communications and Stakeholder Engagement